International Finance and Accounting Handbook

22 • 19

KEY DATA BY REGION

Latin America/

North

Asia/

Africa/

Continuing

Discontinuing

Bayer

Regions

Europe

America

Pacific

Middle East

Reconciliation

Operations

Operations

Group

Euros in millions—2001Net sales (external)—by market

11,659

9,473

4,660

3,146

28,938

1,337

30,275

Net sales (external)—by point of origin

12,999

9,806

3,817

2,316

28,938

1,337

30,275

• Change in euros

+0.6%

+1.1%

+1.5%

+3.4%

+1.1%

–2.2%

• Change in local currencies

+0.5%

–1.9%

+7.3%

+2.5%

+0.8%

–2.5%

Interregional sales

3,154

1,927

226

116

(5,423)

Other operating income

312

70

48

50

480

340

820

Operating result before exceptionals

1,707

23

241

219

(335)

1,855

76

1,931

Return on sales before exceptionals

13.1%

0.2%

6.3%

9.5%

6.4%

6.4%

Exceptional items

(272)

(278)

(14)

(30)

(19)

(613)

293

(320)

Operating result

1,435

(255)

227

189

(354)

1,242

369

1,611

Return on sales

11.0%

–2.6%

5.9%

8.2%

4.3%

5.3%

Gross cash flow

2,037

632

312

225

(380)

2,826

97

2,923

Capital invested

16,355

12,808

2,711

1,607

(15)

33,466

1,392

34,858

CFROI

12.5%

4.7%

11.3%

14.5%

8.3%

8.2%

Equity-method income

12

0

0

0

12

14

26

Equity-method investments

351

618

2

16

987

179

1,166

Total assets

17,298

12,652

3,132

1,834

1,074

35,990

1,049

37,039

Capital expenditures

1,620

560

255

118

0

2,553

64

2,617

Amortization and depreciation

1,227

918

150

104

4

2,403

113

2,516

Liabilities

9,769

6,407

1,382

673

1,481

19,712

307

20,019

Research and development expenses

1,559

690

68

9

162

2,488

71

2,559

Number of employees (as of Dec. 31)

64,600

23,200

12,600

11,000

600

112,000

4,900

116,900

Exhibit 22.4.

(Continued

)